These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Irisin prevents dexamethasone-induced atrophy in C2C12 myotubes. Chang JS; Kong ID Pflugers Arch; 2020 Apr; 472(4):495-502. PubMed ID: 32219531 [TBL] [Abstract][Full Text] [Related]
25. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Wang JC; Derynck MK; Nonaka DF; Khodabakhsh DB; Haqq C; Yamamoto KR Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15603-8. PubMed ID: 15501915 [TBL] [Abstract][Full Text] [Related]
26. Forkhead box O3 plays a role in skeletal muscle atrophy through expression of E3 ubiquitin ligases MuRF-1 and atrogin-1 in Cushing's syndrome. Kang SH; Lee HA; Kim M; Lee E; Sohn UD; Kim I Am J Physiol Endocrinol Metab; 2017 Jun; 312(6):E495-E507. PubMed ID: 28246104 [TBL] [Abstract][Full Text] [Related]
27. Repression of glucocorticoid-stimulated angiopoietin-like 4 gene transcription by insulin. Kuo T; Chen TC; Yan S; Foo F; Ching C; McQueen A; Wang JC J Lipid Res; 2014 May; 55(5):919-28. PubMed ID: 24565756 [TBL] [Abstract][Full Text] [Related]
28. The glucocorticoid receptor and FOXO1 synergistically activate the skeletal muscle atrophy-associated MuRF1 gene. Waddell DS; Baehr LM; van den Brandt J; Johnsen SA; Reichardt HM; Furlow JD; Bodine SC Am J Physiol Endocrinol Metab; 2008 Oct; 295(4):E785-97. PubMed ID: 18612045 [TBL] [Abstract][Full Text] [Related]
29. Endogenous glucocorticoids and impaired insulin signaling are both required to stimulate muscle wasting under pathophysiological conditions in mice. Hu Z; Wang H; Lee IH; Du J; Mitch WE J Clin Invest; 2009 Oct; 119(10):3059-69. PubMed ID: 19759515 [TBL] [Abstract][Full Text] [Related]
30. Class I HDAC inhibitors attenuate dexamethasone-induced muscle atrophy via increased protein kinase C (PKC) delta phosphorylation. Habibian JS; Bolino M; Qian A; Woolsey R; Quilici D; Petereit J; Ferguson BS Cell Signal; 2023 Oct; 110():110815. PubMed ID: 37478958 [TBL] [Abstract][Full Text] [Related]
32. Quantification of hormone-induced atrophy of large myotubes from C2C12 and L6 cells: atrophy-inducible and atrophy-resistant C2C12 myotubes. Sultan KR; Henkel B; Terlou M; Haagsman HP Am J Physiol Cell Physiol; 2006 Feb; 290(2):C650-9. PubMed ID: 16176969 [TBL] [Abstract][Full Text] [Related]
33. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia. Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162 [TBL] [Abstract][Full Text] [Related]
34. Aerobic exercise-mediated changes in the expression of glucocorticoid responsive genes in skeletal muscle differ across the day. Dunlap KR; Laskin GR; Waddell DS; Black AJ; Steiner JL; Vied C; Gordon BS Mol Cell Endocrinol; 2022 Jun; 550():111652. PubMed ID: 35461977 [TBL] [Abstract][Full Text] [Related]
35. TLR13 contributes to skeletal muscle atrophy by increasing insulin resistance in chronic kidney disease. Gu L; Wang Z; Zhang Y; Zhu N; Li J; Yang M; Wang L; Rong S Cell Prolif; 2022 Mar; 55(3):e13181. PubMed ID: 35088922 [TBL] [Abstract][Full Text] [Related]